The foreign vaccine makers are demanding indemnity against legal liability in case of adverse reactions post-vaccination.
The Covid-19 vaccine of Biological-E is currently undergoing phase-3 clinical trial after showing promising results in phase 1 and 2 trials
After the Phase 3 data is submitted, India can expect an increase in the current rate of the immunisation programme.